Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 1Phase 1 1

Status

Completed 2Withdrawn 1Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4NIH 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6

Conditions

Prostatic Neoplasms 5016Carcinoma, Renal Cell 1574Urinary Bladder Neoplasms 1279Kidney Neoplasms 723Breast Neoplasms 642Neoplasms 628Carcinoma, Transitional Cell 487Neoplasm Metastasis 468Carcinoma, Non-Small-Cell Lung 467Melanoma 421Ovarian Neoplasms 399Colorectal Neoplasms 370Lung Neoplasms 333Pancreatic Neoplasms 262Sarcoma 231Stomach Neoplasms 226Uterine Cervical Neoplasms 223Testicular Neoplasms 215Non-Muscle Invasive Bladder Neoplasms 214Head and Neck Neoplasms 192Squamous Cell Carcinoma of Head and Neck 187Colonic Neoplasms 167Carcinoma, Hepatocellular 165Esophageal Neoplasms 164Endometrial Neoplasms 164Wilms Tumor 159Recurrence 131Triple Negative Breast Neoplasms 128Neuroblastoma 127Small Cell Lung Carcinoma 125

Interventions

bintrafusp alfa protein, human 1Triamcinolone Acetonide 1TH 302 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Injections, Intramuscular 1ALT-803 1AGN 194204 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Castration Resistant Prostate Cancer × Genitourinary × Clear all
NCT06836726 2026-01-28

EVO

University Health Network, Toronto

Phase 2 Not yet recruiting
35 enrolled
Genitourinary

Castration Resistant Prostate Cancer

NCT05919329 2025-10-24

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

OHSU Knight Cancer Institute

Phase 4 Recruiting
80 enrolled
Genitourinary

Castration Resistant Prostate Cancer

NCT07161778 2025-09-09

TRICREST

Barts & The London NHS Trust

Phase 2 Completed
55 enrolled
Genitourinary

Castration Resistant Prostate Cancer

NCT05445882 2024-04-02

N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Withdrawn
Genitourinary

Castration Resistant Prostate Cancer

NCT01540071 2021-05-14

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Io Therapeutics

Phase 2 Completed
38 enrolled 11 charts
Genitourinary

Castration Resistant Prostate Cancer

NCT02502994 2015-07-20

Phase 1 Study of GEN0101 in Patients With Recurrence of CRPC

Osaka University

Phase 1 Unknown
12 enrolled
Genitourinary

Castration Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡